EHR-Embedded Decision Support to Prevent Stroke in Patients With AF
Atrial Fibrillation
About this trial
This is an interventional health services research trial for Atrial Fibrillation focused on measuring anticoagulation, decision sciences, clinical informatics, implementation research
Eligibility Criteria
Inclusion Criteria:
- • Diagnosis of non-valvular atrial fibrillation or atrial flutter (I48.x)
Exclusion Criteria:
- • Diagnosis of valvular heart disease (mitral valve disease (I05.x), aortic valve disease (I06.x), mitral and aortic valve disease (I08.x)), presence of prosthetic heart valve (Z95.2), or presence of xenogenic heart valve (Z95.3), or presence of other heart valve replacement (Z95.4).
Sites / Locations
- University of Cincinnati Health System
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Current State
AFDST with BPA
Clinicians of patients randomized to this arm will have access to the Atrial Fibrillation Decision-Support Tool (AFDST) embedded in our EHR (as they do now), but will not receive BPAs alerting them to patients who might benefit significantly from a change in anticoagulation treatment.
Clinicians of patients randomized to this arm will receive BPAs when they are in the medical record of an AF patient who might gain significantly from a change in anticoagulation treatment. In addition, clinicians will have the ability to refer patients to a pharmacist-staffed AF Thromboprophylaxis Shared Decision-Making Service based in our Anticoagulation Clinic.